Meeting of the COVID-19 Health Equity Task Force, 57161 [2021-22330]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 196 / Thursday, October 14, 2021 / Notices
considered by FDA and the Quality
Expert Working Group.
The draft guidance provides guidance
on the development, implementation,
operation, and lifecycle management of
CM.
This draft guidance has been left in
the original ICH format. The final
guidance will be reformatted and edited
to conform with FDA’s good guidance
practices regulation (21 CFR 10.115) and
style before publication. The draft
guidance, when finalized, will represent
the current thinking of FDA on ‘‘Q13
Continuous Manufacturing of Drug
Substances and Drug Products.’’ It does
not establish any rights for any person
and is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations.
II. Paperwork Reduction Act of 1995
While this guidance contains no
collection of information, it does refer to
previously approved FDA collections of
information. Therefore, clearance by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995 (PRA) (44 U.S.C. 3501–
3521) is not required for this guidance.
The previously approved collections of
information are subject to review by
OMB under the PRA. The collections of
information in 21 CFR part 312 have
been approved under OMB control
number 0910–0014; the collections of
information in 21 CFR part 314 have
been approved under OMB control
number 0910–0001; the collections of
information in 21 CFR part 601 have
been approved under OMB control
number 0910–0338; and the collections
of information in 21 CFR parts 210 and
211 have been approved under OMB
control number 0910–0139.
lotter on DSK11XQN23PROD with NOTICES1
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
vaccines-blood-biologics/guidancecompliance-regulatory-informationbiologics/biologics-guidances, https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents, or
https://www.regulations.gov.
Dated: October 8, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–22451 Filed 10–13–21; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
17:44 Oct 13, 2021
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the COVID–19 Health Equity
Task Force
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice of meeting.
AGENCY:
As required by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that the COVID–19 Health Equity Task
Force (Task Force) will hold a virtual
meeting on October 28, 2021. The
purpose of this meeting is to present
and vote on the Task Force Final Report
with recommended Implementation
Plan and Accountability Plan for
mitigating inequities caused or
exacerbated by the COVID–19 pandemic
and for preventing such inequities in
the future. This meeting is open to the
public and will be live-streamed at
www.hhs.gov/live. Information about the
meeting will be posted on the HHS
Office of Minority Health website:
www.minorityhealth.hhs.gov/
healthequitytaskforce/ prior to the
meeting.
SUMMARY:
The Task Force meeting will be
held on Thursday, October 28, 2021,
from 1 p.m. to approximately 4 p.m. ET
(date and time are tentative and subject
to change). The confirmed time and
agenda will be posted on the COVID–19
Health Equity Task Force web page:
www.minorityhealth.hhs.gov/
healthequitytaskforce/ when this
information becomes available.
FOR FURTHER INFORMATION CONTACT:
Samuel Wu, Designated Federal Officer
for the Task Force; Office of Minority
Health, Department of Health and
Human Services, Tower Building, 1101
Wootton Parkway, Suite 100, Rockville,
Maryland 20852. Phone: 240–453–6173;
email: COVID19HETF@hhs.gov.
SUPPLEMENTARY INFORMATION:
Background: The COVID–19 Health
Equity Task Force (Task Force) was
established by Executive Order 13995,
dated January 21, 2021. The Task Force
is tasked with providing specific
recommendations to the President,
through the Coordinator of the COVID–
19 Response and Counselor to the
President (COVID–19 Response
Coordinator), for mitigating the health
inequities caused or exacerbated by the
COVID–19 pandemic and for preventing
such inequities in the future. The Task
Force shall submit a final report to the
COVID–19 Response Coordinator
DATES:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
57161
addressing any ongoing health
inequities faced by COVID–19 survivors
that may merit a public health response,
describing the factors that contributed to
disparities in COVID–19 outcomes, and
recommending actions to combat such
disparities in future pandemic
responses.
The meeting is open to the public and
will be live-streamed at www.hhs.gov/
live. No registration is required. A
public comment session will be held
during the meeting. Pre-registration is
required to provide public comment
during the meeting. To pre-register,
please send an email to
COVID19HETF@hhs.gov and include
your name, title, and organization by
close of business on Friday, October 22,
2021. Comments will be limited to no
more than three minutes per speaker
and should be pertinent to the meeting
discussion. Individuals are encouraged
to provide a written statement of any
public comment(s) for accurate minutetaking purposes. If you decide you
would like to provide public comment
but do not pre-register, you may submit
your written statement by emailing
COVID19HETF@hhs.gov no later than
close of business on Thursday,
November 4, 2021. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should contact:
COVID19HETF@hhs.gov and reference
this meeting. Requests for special
accommodations should be made at
least 10 business days prior to the
meeting.
Dated: October 7, 2021.
Samuel Wu,
Designated Federal Officer, COVID–19 Health
Equity Task Force.
[FR Doc. 2021–22330 Filed 10–13–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Secretary’s Advisory
Committee on Human Research
Protections
Office of the Secretary, Office
of the Assistant Secretary for Health,
Department of Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
Pursuant to Section 10(a) of
the Federal Advisory Committee Act,
notice is hereby given that the
Secretary’s Advisory Committee on
Human Research Protections (SACHRP)
will hold a meeting that will be open to
the public.
SUMMARY:
E:\FR\FM\14OCN1.SGM
14OCN1
]]>Agencies
[Federal Register Volume 86, Number 196 (Thursday, October 14, 2021)]
[Notices]
[Page 57161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the COVID-19 Health Equity Task Force
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: As required by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services (HHS) is hereby giving notice
that the COVID-19 Health Equity Task Force (Task Force) will hold a
virtual meeting on October 28, 2021. The purpose of this meeting is to
present and vote on the Task Force Final Report with recommended
Implementation Plan and Accountability Plan for mitigating inequities
caused or exacerbated by the COVID-19 pandemic and for preventing such
inequities in the future. This meeting is open to the public and will
be live-streamed at www.hhs.gov/live. Information about the meeting
will be posted on the HHS Office of Minority Health website:
www.minorityhealth.hhs.gov/healthequitytaskforce/ prior to the meeting.
DATES: The Task Force meeting will be held on Thursday, October 28,
2021, from 1 p.m. to approximately 4 p.m. ET (date and time are
tentative and subject to change). The confirmed time and agenda will be
posted on the COVID-19 Health Equity Task Force web page:
www.minorityhealth.hhs.gov/healthequitytaskforce/ when this information
becomes available.
FOR FURTHER INFORMATION CONTACT: Samuel Wu, Designated Federal Officer
for the Task Force; Office of Minority Health, Department of Health and
Human Services, Tower Building, 1101 Wootton Parkway, Suite 100,
Rockville, Maryland 20852. Phone: 240-453-6173; email:
[email protected].
SUPPLEMENTARY INFORMATION:
Background: The COVID-19 Health Equity Task Force (Task Force) was
established by Executive Order 13995, dated January 21, 2021. The Task
Force is tasked with providing specific recommendations to the
President, through the Coordinator of the COVID-19 Response and
Counselor to the President (COVID-19 Response Coordinator), for
mitigating the health inequities caused or exacerbated by the COVID-19
pandemic and for preventing such inequities in the future. The Task
Force shall submit a final report to the COVID-19 Response Coordinator
addressing any ongoing health inequities faced by COVID-19 survivors
that may merit a public health response, describing the factors that
contributed to disparities in COVID-19 outcomes, and recommending
actions to combat such disparities in future pandemic responses.
The meeting is open to the public and will be live-streamed at
www.hhs.gov/live. No registration is required. A public comment session
will be held during the meeting. Pre-registration is required to
provide public comment during the meeting. To pre-register, please send
an email to [email protected] and include your name, title, and
organization by close of business on Friday, October 22, 2021. Comments
will be limited to no more than three minutes per speaker and should be
pertinent to the meeting discussion. Individuals are encouraged to
provide a written statement of any public comment(s) for accurate
minute-taking purposes. If you decide you would like to provide public
comment but do not pre-register, you may submit your written statement
by emailing [email protected] no later than close of business on
Thursday, November 4, 2021. Individuals who plan to attend and need
special assistance, such as sign language interpretation or other
reasonable accommodations, should contact: [email protected] and
reference this meeting. Requests for special accommodations should be
made at least 10 business days prior to the meeting.
Dated: October 7, 2021.
Samuel Wu,
Designated Federal Officer, COVID-19 Health Equity Task Force.
[FR Doc. 2021-22330 Filed 10-13-21; 8:45 am]
BILLING CODE 4150-29-P
